Cccccccccccc
2022-12-13

[Sigh] [Sigh] 

波士頓科學向先瑞達醫療發起部分要約

@财见：
波士頓科學公司與先瑞達醫療科技控股有限公司宣佈，波士頓科學將發起部分要約，以收購先瑞達最多不超過65%股份的多數股權，先瑞達是一家中國醫療科技企業，針對各類介入手術提供解決方案。該交易擬議價格爲每股20港元，按當前匯率計算，65%股權的現金對價約爲5.23億美元。先瑞達是創新醫療解決方案領域的領軍企業，提供包括用於治療血管和其他疾病的藥物塗層球囊(DCB)在內的產品組合。(醫藥健聞)
波士頓科學向先瑞達醫療發起部分要約

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet